Tuesday, 3 June 2008

Vaccine against glioblastoma muliforme developed

Research suggests that patients who received the vaccine lived on average three years longer than whose who didn't receive the vaccine.

The vaccine contains a protein found on about 50% of tumours.

The vaccine causes the immune system to destroy cancer cells in the brain.

Further research is going to be carried out.

No comments: